retatrutide type 2 diabetes phase 2 results a1c 🩺 in diabetes: TRANSCEND-T2D-1 3 → HbA1c ↓2.0% + weight ↓16.8% at 40 weeks. A triple agonist that tackles both glycemia and obesity simultaneously. 📊💊 Ref: Lilly retatrutide type 2 diabetes phase

The HGF receptor pathway is a well-characterized signaling system in the body, and you can review the role of hepatocyte growth factor in tissue and neural signaling through the National Center for Biotechnology Information

International Journal of Molecular Sciences, 19 (7), 1987.

Front Oncol (2021) 11:727130

In addition to the relevance of POP conjugation cited previously, hyperglycemia and hyperinsulinemia appear to directly inhibit glutathione synthesis (GCL), and the increased production of reactive oxygen species which accompanies diabetes further depletes GSH levels

The company said it plans to submit the drug for FDA approval in early 2027

doi: 10.1073/pnas.0904747106 87 SantolloJYaoDNeal-PerryGEtgenAM